drugset
drugset / Trial / NCT00304356

Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection

NCT00304356 ↗

Phase 3 Completed 22 enrolled Daniel M. Musher MD Baylor College of Medicine · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is for compassionate use of nitazoxanide in the treatment of diarrheal disease due to Clostridium difficile infection when the patient has failed previous treatment with metronidazole or vancomycin.

Timeline

Start
2004-01
Primary completion
2007-01
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitazoxanide Other / unclassified 500 mg Oral

Indications

Clostridium difficile colitis